Evaluation of Infants With Intrauterine Growth Restriction
NCT ID: NCT02515292
Last Updated: 2015-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2014-06-30
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives:
1. IGF1 and IGF2 evaluation of serum and IGF1 receptor, IGF2 receptor and IGF2 receptor gene expression in cord blood from newborns with intrauterine growth restriction (IUGR). (Prospective)
2. Evaluation and monitoring of anthropometric, clinical (non-cardiac morbidity) and paraclinical. (Retrospective \& prospective)
3. Evaluation and monitoring of morphological and functional by echocardiography. (Prospective)
4. Integrating multidimensional clinical and paraclinical parameters in a statistical model for evaluating newborn with intrauterine growth restriction.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Follow-up Protocols in Terms of Fetal, Neonatal and Maternal Results in Intrauterine Growth Retardation
NCT04141189
Constructing an Insulin-Like Growth Factor-based Prediction Model
NCT00263445
Treatment of Intrauterine Growth Restriction With Low Molecular Heparin.
NCT03324139
Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight
NCT00120497
Fetal Growth Pattern in Short Stature Women
NCT04213443
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IUGR: newborn with intrauterine growth restriction
Inclusion criteria:
* newborn infants with symmetrical (both weight and height lower than 10th percentile) or asymmetrical (birth weight is lower than 10th percentile but height and age-appropriated height) intrauterine growth restriction
* agreement of the parents that their child to be included in the study
No interventions assigned to this group
control: newborn without intrauterine growth restriction
Inclusion criteria:
\- matches newborn without intrauterine growth restriction in terms of gender and gestational age as IUGR group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* parental consent for enrollment
Exclusion Criteria
* neonates with congenital heart disease
* twins
* refusal of parents for participation to the study
24 Hours
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Iuliu Hatieganu University of Medicine and Pharmacy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hășmășanu Monica Gabriela
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gabriela Zaharie, PhD, MD
Role: STUDY_CHAIR
Iuliu Hațieganu Medicine and pharmacy University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Neonatal-Ward, 1st Gynecology Clinic
Cluj-Napoca, Cluj, Romania
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
142 /181/ 20.05.2014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.